COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,790 Articles (22,523 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 1409: Articles 14081-14090  | Next

Anti-SARS-CoV-2 potential of Cissampelos pareira L. identified by Connectivity map-based analysis and in vitro studies
Haider, M., Anand, V., Dholakia, D., Enayathullah, M. G., Parekh, Y., Ram, S., Kumari, S., K, A., Bokara, K. K., Sharma, U., Prasher, B., Mukerji, M.
10.1101/2021.06.11.448155 — Posted: 2021-06-13
UK B.1.1.7 variant exhibits increased respiratory replication and shedding in nonhuman primates
Rosenke, K., Feldmann, F., Okumura, A., Hansen, F., Tang-Huau, T.-L., Meade-White, K., Kaza, B., Smith, B. J., Hanley, P. W., Lovaglio, J., Jarvis, M., Shaia, C., Feldmann, H.
10.1101/2021.06.11.448134 — Posted: 2021-06-13
Deaths involving COVID-19 by disability status: a retrospective analysis of 29 million adults during the first two waves of the Coronavirus pandemic in England
Bosworth, M. L., Ayoubkhani, D., Nafilyan, V., Foubert, J., Glickman, M., Davey, C., Kuper, H.
10.1101/2021.06.10.21258693 — Posted: 2021-06-13
Topology identifies emerging adaptive mutations in SARS-CoV-2
Bleher, M., Hahn, L., Patino-Galindo, J. A., Carriere, M., Bauer, U., Rabadan, R., Ott, A.
10.1101/2021.06.10.21258550 — Posted: 2021-06-13
Convalescent Plasma in Critically ill Patients with COVID-19
The REMAP-CAP Investigators, , Estcourt, L. J.
10.1101/2021.06.11.21258760 — Posted: 2021-06-13
Cross-neutralizing activity against SARS-CoV-2 variants in COVID-19 patients: Comparison of four waves of the pandemic in Japan
Furukawa, K., Tjan, L. H., Sutandhio, S., Kurahashi, Y., Iwata, S., Tohma, Y., Sano, S., Nakamura, S., Nishimura, M., Arii, J., Kiriu, T., Yamamoto, M., Nagano, T., Nishimura, Y., Mori, Y.
10.1101/2021.06.10.21258682 — Posted: 2021-06-13
Early Prediction of In-Hospital Death of COVID-19 Patients: A Machine-Learning Model Based on Age, Blood Analyses, and Chest X-Ray Score
Garrafa, E., Vezzoli, M., Ravanelli, M., Farina, D., Borghesi, A., Calza, S., Maroldi, R.
10.1101/2021.06.10.21258721 — Posted: 2021-06-13
Risk factors for hospitalization, disease severity and mortality in children and adolescents with COVID-19: Results from a nationwide German registry
Armann, J. P., Doenhardt, M., Hufnagel, M., Diffloth, N., Reichert, F., Haas, W., Schilling, J., Haller, S., Huebner, J., Simon, A., Schneider, D. T., Brunner, J., Trotter, A., Roessler, M., Schmitt, J., Berner, R.
10.1101/2021.06.07.21258488 — Posted: 2021-06-13
Determinants of adherence to COVID-19 preventive behaviours in Canada: Results from the iCARE Study
Lavoie, K. L., Gosselin Boucher, V., Stojanovic, J., Voisard, B., Szczepanik, G., Boyle, J. A., Belanger-Gravel, A., Bacon, S. L.
10.1101/2021.06.09.21258634 — Posted: 2021-06-13
Evaluation and clinical implications of the time to a positive results of antigen testing for SARS-CoV-2
Akashi, Y., Kiyasu, Y., Takeuchi, Y., Kato, D., Kuwahara, M., Muramatsu, S., Ueda, A., Notake, S., Nakamura, K., Ishikawa, H., Suzuki, H.
10.1101/2021.06.09.21258157 — Posted: 2021-06-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).